Recent clinical development of minimally invasive closure for atrial septal defect_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

ZHOU Qi ¹ , HAN Yu ² , SONG Shubo ¹ , FAN Taibing ¹ ,  PAN Xiangbin ³

1. Department of Cardiac Surgery, Zhengzhou University People's Hospital, Zhengzhou, 450003, P.R.China;
2. Department of Structural Heart Disease, Fuwai Central China Cardiovascular Hospital, Zhengzhou, 450003, P.R.China;
3. Department of Structural Heart Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing, 100037, P.R.China;

Corresponding author：

PAN Xiangbin, Email: panxiangbin@fuwaihospital.org

Keywords：

Atrial septal defect; occluder; minimally invasive occlusion; echocardiography guidance; review

DOI：

10.7507/1007-4848.202008057

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Atrial septal defect (ASD) is a congenital heart disease that causes blood communication between the left and right ventricles due to partial atrial septal tissue defects, accounting for about 13% of all heart malformations. Secondary ASD is the most common type of ASD and can generally be treated with minimally invasive closure. At present, the commonly used minimally invasive methods in clinical practice mainly include X-ray-guided percutaneous occlusion, transesophageal ultrasound-guided transthoracic occlusion and ultrasound-guided percutaneous occlusion. This review focuses on the basic research process of occluder materials, and advantages and disadvantages of three different surgical methods.

Citation： ZHOU Qi, HAN Yu, SONG Shubo, FAN Taibing, PAN Xiangbin. Recent clinical development of minimally invasive closure for atrial septal defect. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2021, 28(12): 1508-1512. doi: 10.7507/1007-4848.202008057 Copy

1.	King TD, Mills NL. Nonoperative closure of atrial septal defects. Surgery, 1974, 75(3): 383-388.
2.	Fischer G, Kramer HH, Stieh J, et al. Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer Septal Occluder. Eur Heart J, 1999, 20(7): 541-549.
3.	Behjati M, Rafiei M, Soltani MH, et al. Transcatheter closure of atrial septal defect with amplatzer septal occluder in adults: Immediate, short, and intermediate-term results. J Tehran Heart Cent, Spring 2011, 6(2): 79-84.
4.	McElhinney DB, Quartermain MD, Kenny D, et al. Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: A case-control study. Circulation, 2016, 133(18): 1738-1746.
5.	Tang B, Su F, Sun X, et al. Recent development of transcatheter closure of atrial septal defect and patent foramen ovale with occluders. J Biomed Mater Res B Appl Biomater, 2018, 106(1): 433-443.
6.	Jux C, Bertram H, Wohlsein P, et al. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: Development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol, 2006, 48(1): 161-169.
7.	Li BN, Xie YM, Xie ZF, et al. Study of biodegradable occluder of atrial septal defect in a porcine model. Catheter Cardiovasc Interv, 2019, 93(1): E38-E45.
8.	Zhu YF, Huang XM, Cao J, et al. Animal experimental study of the fully biodegradable atrial septal defect (ASD) occluder. J Biomed Biotechnol, 2012, 2012: 735989.
9.	戴柯, 李奋, 孙康, 等. 全生物可降解型房间隔缺损封堵器封堵猪房间隔缺损的实验研究. 临床儿科杂志, 2010, 28(4): 375-379.
10.	Li YF, Xie YM, Chen J, et al. Initial experiences with a novel biodegradable device for percutaneous closure of atrial septal defects: From preclinical study to first-in-human experience. Catheter Cardiovasc Interv, 2020, 95(2): 282-293.
11.	Jalal Z, Hascoët S, Gronier C, et al. Long-term outcomes after percutaneous closure of ostium secundum atrial septal defect in the young: A Nationwide cohort study. JACC Cardiovasc Interv, 2018, 11(8): 795-804.
12.	Villablanca PA, Briston DA, Rodés-Cabau J, et al. Treatment options for the closure of secundum atrial septal defects: A systematic review and meta-analysis. Int J Cardiol, 2017, 241: 149-155.
13.	Haas NA, Soetemann DB, Ates I, et al. Closure of secundum atrial septal defects by using the occlutech occluder devices in more than 1300 patients: The IRFACODE project: A retrospective case series. Catheter Cardiovasc Interv, 2016, 88(4): 571-581.
14.	Turner DR, Owada CY, Sang CJ, et al. Closure of secundum atrial septal defects with the Amplatzer septal occluder: A prospective, multicenter, post-approval study. Circ Cardiovasc Interv, 2017, 10(8): e004212.
15.	Roguin A, Goldstein J, Bar O, et al. Brain and neck tumors among physicians performing interventional procedures. Am J Cardiol, 2013, 111(9): 1368-1372.
16.	Yakoumakis EN, Gialousis GI, Papadopoulou D, et al. Estimation of children's radiation dose from cardiac catheterisations, performed for the diagnosis or the treatment of a congenital heart disease using TLD dosimetry and Monte Carlo simulation. J Radiol Prot, 2009, 29(2): 251-261.
17.	Tanaka A, Suzuki Y, Suzuki N, et al. Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction? Intern Med, 2011, 50(7): 673-677.
18.	窦志, 谢琦, 翁国星, 等. 经胸超声与经食管超声引导下经皮房间隔缺损封堵术的比较研究. 中华胸心血管外科杂志, 2018, 34(9): 522-526.
19.	范太兵, 宋书波, 梁维杰, 等. 右腋下切口外科微创封堵术治疗房间隔缺损. 中华实用儿科临床杂志, 2015, 30(7): 538-540.
20.	Pan XB, Ou-Yang WB, Pang KJ, et al. Percutaneous closure of atrial septal defects under transthoracic echocardiography guidance without fluoroscopy or intubation in children. J Interv Cardiol, 2015, 28(4): 390-395.
21.	韩宇, 范太兵, 彭帮田, 等. 单纯食管超声心动图引导经右颈内静脉封堵房间隔缺损早期随访结果. 中华实用儿科临床杂志, 2016, 31(13): 986-988.
22.	张大伟, 潘湘斌, 李萍, 等. 单纯超声引导经颈静脉封堵治疗婴幼儿房间隔缺损. 中华医学杂志, 2019, 99(6): 458-461.
23.	O'Byrne ML, Glatz AC, Gillespie MJ. Transcatheter device closure of atrial septal defects: More to think about than just closing the hole. Curr Opin Cardiol, 2018, 33(1): 108-116.
24.	Ali M, Salah El-Din H, Bakhoum S, et al. Feasibility of percutaneous closure of atrial septal defects in adults under transthoracic echocardiography guidance using the Figulla atrial septal defect occluder device. J Saudi Heart Assoc, 2018, 30(1): 21-27.
25.	刘垚, 温彬, 张凤文, 等. 新型导丝系统在超声引导房间隔缺损封堵术中的应用价值. 中国胸心血管外科临床杂志, 2019, 26(2): 165-168.
26.	Kong P, Zhao G, Zhang Z, et al. Novel panna guide wire facilitates percutaneous and nonfluoroscopic procedure for atrial septal defect closure: A randomized controlled trial. Circ Cardiovasc Interv, 2020, 13(9): e9281.

1. King TD, Mills NL. Nonoperative closure of atrial septal defects. Surgery, 1974, 75(3): 383-388.
2. Fischer G, Kramer HH, Stieh J, et al. Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer Septal Occluder. Eur Heart J, 1999, 20(7): 541-549.
3. Behjati M, Rafiei M, Soltani MH, et al. Transcatheter closure of atrial septal defect with amplatzer septal occluder in adults: Immediate, short, and intermediate-term results. J Tehran Heart Cent, Spring 2011, 6(2): 79-84.
4. McElhinney DB, Quartermain MD, Kenny D, et al. Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: A case-control study. Circulation, 2016, 133(18): 1738-1746.
5. Tang B, Su F, Sun X, et al. Recent development of transcatheter closure of atrial septal defect and patent foramen ovale with occluders. J Biomed Mater Res B Appl Biomater, 2018, 106(1): 433-443.
6. Jux C, Bertram H, Wohlsein P, et al. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: Development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol, 2006, 48(1): 161-169.
7. Li BN, Xie YM, Xie ZF, et al. Study of biodegradable occluder of atrial septal defect in a porcine model. Catheter Cardiovasc Interv, 2019, 93(1): E38-E45.
8. Zhu YF, Huang XM, Cao J, et al. Animal experimental study of the fully biodegradable atrial septal defect (ASD) occluder. J Biomed Biotechnol, 2012, 2012: 735989.
9. 戴柯, 李奋, 孙康, 等. 全生物可降解型房间隔缺损封堵器封堵猪房间隔缺损的实验研究. 临床儿科杂志, 2010, 28(4): 375-379.
10. Li YF, Xie YM, Chen J, et al. Initial experiences with a novel biodegradable device for percutaneous closure of atrial septal defects: From preclinical study to first-in-human experience. Catheter Cardiovasc Interv, 2020, 95(2): 282-293.
11. Jalal Z, Hascoët S, Gronier C, et al. Long-term outcomes after percutaneous closure of ostium secundum atrial septal defect in the young: A Nationwide cohort study. JACC Cardiovasc Interv, 2018, 11(8): 795-804.
12. Villablanca PA, Briston DA, Rodés-Cabau J, et al. Treatment options for the closure of secundum atrial septal defects: A systematic review and meta-analysis. Int J Cardiol, 2017, 241: 149-155.
13. Haas NA, Soetemann DB, Ates I, et al. Closure of secundum atrial septal defects by using the occlutech occluder devices in more than 1300 patients: The IRFACODE project: A retrospective case series. Catheter Cardiovasc Interv, 2016, 88(4): 571-581.
14. Turner DR, Owada CY, Sang CJ, et al. Closure of secundum atrial septal defects with the Amplatzer septal occluder: A prospective, multicenter, post-approval study. Circ Cardiovasc Interv, 2017, 10(8): e004212.
15. Roguin A, Goldstein J, Bar O, et al. Brain and neck tumors among physicians performing interventional procedures. Am J Cardiol, 2013, 111(9): 1368-1372.
16. Yakoumakis EN, Gialousis GI, Papadopoulou D, et al. Estimation of children's radiation dose from cardiac catheterisations, performed for the diagnosis or the treatment of a congenital heart disease using TLD dosimetry and Monte Carlo simulation. J Radiol Prot, 2009, 29(2): 251-261.
17. Tanaka A, Suzuki Y, Suzuki N, et al. Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction? Intern Med, 2011, 50(7): 673-677.
18. 窦志, 谢琦, 翁国星, 等. 经胸超声与经食管超声引导下经皮房间隔缺损封堵术的比较研究. 中华胸心血管外科杂志, 2018, 34(9): 522-526.
19. 范太兵, 宋书波, 梁维杰, 等. 右腋下切口外科微创封堵术治疗房间隔缺损. 中华实用儿科临床杂志, 2015, 30(7): 538-540.
20. Pan XB, Ou-Yang WB, Pang KJ, et al. Percutaneous closure of atrial septal defects under transthoracic echocardiography guidance without fluoroscopy or intubation in children. J Interv Cardiol, 2015, 28(4): 390-395.
21. 韩宇, 范太兵, 彭帮田, 等. 单纯食管超声心动图引导经右颈内静脉封堵房间隔缺损早期随访结果. 中华实用儿科临床杂志, 2016, 31(13): 986-988.
22. 张大伟, 潘湘斌, 李萍, 等. 单纯超声引导经颈静脉封堵治疗婴幼儿房间隔缺损. 中华医学杂志, 2019, 99(6): 458-461.
23. O'Byrne ML, Glatz AC, Gillespie MJ. Transcatheter device closure of atrial septal defects: More to think about than just closing the hole. Curr Opin Cardiol, 2018, 33(1): 108-116.
24. Ali M, Salah El-Din H, Bakhoum S, et al. Feasibility of percutaneous closure of atrial septal defects in adults under transthoracic echocardiography guidance using the Figulla atrial septal defect occluder device. J Saudi Heart Assoc, 2018, 30(1): 21-27.
25. 刘垚, 温彬, 张凤文, 等. 新型导丝系统在超声引导房间隔缺损封堵术中的应用价值. 中国胸心血管外科临床杂志, 2019, 26(2): 165-168.
26. Kong P, Zhao G, Zhang Z, et al. Novel panna guide wire facilitates percutaneous and nonfluoroscopic procedure for atrial septal defect closure: A randomized controlled trial. Circ Cardiovasc Interv, 2020, 13(9): e9281.

Previous Article
Research progress on risk factors for acute aortic dissection complicated with acute lung injury
Next Article
Research progress on cognitive function in adults with congenital heart disease

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Recent clinical development of minimally invasive closure for atrial septal defect

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content